Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes.
BACKGROUND
The prevalence of gastroparesis in type 2 diabetes mellitus (T2DM) vary widely. Our aim is to estimate the prevalence of clinical symptoms of gastroparesis among patients with type 2 diabetes mellitus and explore the relationship between gastroparesis and other risk factors.


METHODS
A cross-sectional study evaluating 147 type 2 diabetics using the Gastroparesis Cardinal Symptoms Index (GCSI). A GCSI Total Score ≥ 1.90 were chosen as having definite symptoms of gastroparesis. All patients completed a demographic questionnaire and interviewed to complete the. Demographic Data, disease duration, Medication, comorbidities, recent blood glucose and HbA1C were collected and investigated.


RESULTS
The prevalence of clinical symptoms of gastroparesis among type 2 diabetics was 10.8%. Clinical symptoms of gastroparesis were significantly correlated to HbA1c (p=0.001), blood glucose (p= 0.003), duration of diabetes (p= 0.02) and comorbidities (p=0.009). The most common symptoms were bloating, stomach fullness and early satiety (63.94%, 55.1% and 48.3% respectively). In logistic regression analysis, female gender emerged as significant independent predictors of the presence of at least one symptom.


CONCLUSIONS
The prevalence of clinical symptoms of gastroparesis observed in the Saudi patientsdiagnosedwithtype2 diabetes was 10.8% and is independently associated with poor controlled diabetes, hyperglycemia, and long duration of diabetes and history of Co-morbid conditions.
Qassim University College of Medicine, Email: Dr.rakanalmogbel@gmail.com Tel: +966563324555.
Rakan A
RA
Almogbel
Qassim University College of Medicine, Email: Fulwa.Alhussan@gmail.com Tel: +966543044220.
Fulwa A
FA
Alhussan
Qassim University College of Medicine, Email: Suliman.alnasser1@gmail.com Tel: +966505298884.
Sulaiman A
SA
Alnasser
Diabetologist Consultant, Assistant Professor of Family Medicine, Qassim University - College of Medicine, Email: mgeffari@qumed.edu.sa Tel: +966504950590.
Metab A
MA
Algeffari